Recent studies have suggested a selective effect of atrial natriuretic peptide (ANP) in regulating NaCI reabsorption in juxtamedullary nephrons. We examined (a) functional differences between medullary thick ascending limbs from long and short loops of Henle (IMAL and sMAL, respectively) and (b) the interaction of ANP and arginine vasopressin (AVP) on Cltransport (Ja) in these two segments. AVP-, glucagon-, and calcitonin-stimulated cAMP accumulation was higher in IMAL than in sMAL. 10-10 M AVP increased Ja in IMAL but not in sMAL. ANP-stimulated cGMP production was higher in IMAL than in sMAL. 10' and 10-M ANP inhibited AVP- 
Introduction
Acting through cyclic GMP (cGMP), atrial natriuretic peptide (ANP)' causes numerous important physiological effects, such as natriuresis, diuresis, smooth muscle relaxation, and a decrease in blood pressure (1) (2) (3) (4) . However, the mechanism of the natriuresis and diuresis caused by ANP is still incompletely understood (5) . The chief target sites for ANP in the kidney have been considered to be glomeruli and inner medullary collecting ducts (IMCD) (1) (2) (3) (4) (5) . ANP increases the glomerular filtration rate (1) (2) (3) (4) and inhibits water and Na reabsorption in IMCD (6) (7) (8) (9) (10) (11) . ANP also inhibits water and NaCl reabsorption in cortical collecting ducts (CCD) (12, 13 ), but those effects may not fully explain ANP-induced natriuresis and diuresis (5) . Micropuncture studies have suggested an action site upstream of the IMCD and the possibility that ANP selectively inhibits NaCl reabsorption in juxtamedullary nephrons (7, 14) , that is, in the subpopulation of nephrons with long loops of Henle that reach into the inner medulla. The medullary thick ascending limb of Henle's loop (MAL) has the largest ability to absorb NaCl among distal nephron segments ( 15) and provides the chemical potential energy that drives the renal countercurrent multiplication system. However, MAL was reported to be insensitive to ANP in rabbits, when ANP was applied to nonstimulated tubules ( 16).
Arginine vasopressin (AVP), a key hormone for urine concentration, has been reported to stimulate adenylate cyclase in MAL ofrodents ( 17) and NaCl transport in MAL ofthe mouse and the Brattleboro rat, but not in the human and the rabbit (18) (19) (20) (21) . There are two types ofMAL: that from long and from short loops of Henle (IMAL and sMAL, respectively). The ratio of long to short loops of Henle differs among species.
Humans and rats have more short loops than long loops, whereas rabbits have more long loops than short loops (22, 23) . Functional differences between 1MAL and sMAL have not yet been demonstrated. Some of the action of ANP is caused by interaction with other hormones. ANP has been reported to inhibit AVP action in collecting ducts (6, 12, 13) . However, there are no reports concerning interaction of ANP and AVP in MAL. We hypothesized that: (a) there is internephron heterogeneity in MAL; 1MAL and sMAL exhibit distinct regulation oftransport functions, especially by AVP; and (b) a portion of the natriuretic action of ANP may be due to inhibition of AVP-stimulated NaCl reabsorption in one or more of these segments. Consequently, we investigated the functional differences between 1MAL and sMAL, and the interaction of ANP and AVP on C1-transport (J0) in these two segments of rats.
Methods ing 1 mg/ml collagenase (type 1, 300 U/mg) and 1 mg/ml BSA. Coronal slices were incubated in the dissection solution containing collagenase for 30 min at 370C under aeration with 100% 02. After the incubation, the slices were washed with the dissection solution. Microdissection was performed using needles under a stereomicroscope at 6-80C in the dissection solution containing 0.05% BSA.
1MAL and sMAL were dissected from the inner stripe of the outer medulla. Fig. 1 is a photograph of microdissected 1MAL and sMAL. 1MAL was confirmed by the attachment of the thin ascending limb, which comes from the inner medulla. sMAL was identified by the bend and by the attachment ofthe thin descending limb, which comes from the outer stripe of the outer medulla. sMAL was consistently larger in diameter than 1MAL. The thin ascending limbs were much thicker than the thin descending limbs.
The dissection solution had the following composition (in mM): 130 NaCl, 5 KCI, 1 NaH2PO4, 1 MgSO4, 1 Ca lactate, 2 Na acetate, 5.5 glucose, S L-alanine, 2 L-leucine, 10 Hepes; pH was adjusted to 7.4 by adding NaOH.
After microdissection, tubular length was measured by means ofan ocular micrometer. A 5-to 10-mm-long IMAL or sMAL was used for a single determination of cAMP content. A 30-to 80-mm-long 1MAL or sMAL was used for a single determination of cGMP content.
We used previously described procedures (24, 25) for the measurement of cyclic nucleotide contents. Microdissected IMAL and sMAL were transferred with 2 IMl of the dissection solution containing 0.05% BSA, using a siliconized glass pipette, into 1.5-ml plastic centrifuge tubes containing 18 ul of the dissection solution with 0.5 mM 3-isobu-. .~~-N LimaR-i Figure 1 . A photograph of IMAL (right) and sMAL (middle). Two sMAL are shown in the middle. The outer medullary collecting duct from the inner stripe of the outer medulla is shown at the left for comparison. IMAL and sMAL were dissected after collagenase treatment of kidney slices (24, 25) . Note that the sMAL begins just before the bend and is thicker than the IMAL.
tyl-l-methylxanthine. The samples were incubated for 10 min at 370C before the addition of peptide hormone (AVP, salmon calcitonin, glucagon, or ANP). After a 3-min incubation, the reaction was stopped by the addition of 50 ,l of ice-cold trichloroacetic acid (TCA). Each tube was centrifuged for 5 min at 3,000 rpm at 40C. 75 Ml ofsupernatant was stored at -20'C until the assay of cyclic nucleotide. Blank samples containing medium and TCA without nephron segments were also stored for use as standards in each experiment.
Frozen samples were thawed at room temperature, and TCA was extracted by water-saturated ether. Samples were dried, and 100 Ml of 50 mM sodium acetate buffer (pH 6.2) was added. cAMP (2.5-1,000 fmol) and cGMP (0.5-1,000 fmol) standards in 50 mM sodium acetate buffer were added to blank samples. Samples and standards were acetylated and assayed for cAMP or cGMP by using radioimmunoassay kits (New England Nuclear, Boston, MA).
Na-K-A TPase activity. Na-K-ATPase activity in IMAL and sMAL was determined as described previously with a slight modification (26) . Briefly, dissected IMAL and sMAL were stored in 10 Ml of solution and permeabilized by freeze-thawing. 10 Ml ofincubation medium was added to each sample. The final composition of the incubation medium was as follows (in mM): 120 NaCl, 10 KC1, 100 imidazole, 5 MgCl2, 1 EGTA, 10 Na2ATP, 20 phosphoenolpyruvate, 2 ascorbic acid, 2 NADH, 2.8 U/ ml pyruvate kinase, 4 U/ml lactate dehydrogenase; pH 7.0. NaCl and KCI were replaced by 130 mM choline Cl, and 1 mM ouabain was added for the assay of ouabain-insensitive ATPase activity. Each sample was incubated for 10 min at 370C, and the reaction was stopped by the addition of20 Ml of0.5 N HC1. After 20 min at room temperature, 40 Ml ofacidified sample was transferred to 600 Ml of 6 N NaOH and immediately mixed. The tube was placed at 60°C for 60 min in the dark, to convert the NAD to a condensed form ofNAD. The fluorescence in each tube was measured. Various amounts of ADP were added to an incubation medium for use as standards.
Because Ja decreased with time in both lMAL and sMAL in the absence of AVP (see Results), we also examined whether Na-K-ATPase activity decreases with time. IMAL or sMAL was incubated in perfusion solution (see below) for 30 min at 37°C in the presence of5% C02-95% 02. Na-K-ATPase activity was compared before and after the incubation in both IMAL and sMAL.
A 5-to 10-mm-long lMAL or sMAL was used for a single determination of Na-K-ATPase activity. Total ATPase activity was determined in the absence of ouabain, and ouabain-insensitive ATPase activity was determined in the presence of 1 mM ouabain. Na-K-ATPase activity was determined as the ouabain-sensitive ATPase activity (total ATPase activity minus ouabain-insensitive ATPase activity).
Fluid transport study using isolated tubule perfusion. MAL has been reported to be impermeable to water (18) (19) (20) (21) 27) . The absence of fluid absorption in lMAL and sMAL was examined using isolated tubule perfusion ( 13, 28) . lMAL or sMAL was obtained without collagenase treatment. Rats were decapitated and coronal slices ofthe kidneys were used for dissection. The dissection solution was the same as mentioned above, and it was continuously gassed with 100% 02-IMAL or sMAL was dissected with forceps and perfused in vitro at 37°C. The perfusion solution and the bath solution were identical and had the following composition (in mM): 18 NaCl, 25 NaHCO3, 2.5 K2HPO4, 1 MgSO4, 1 Ca lactate, 2 Na acetate, 5.5 glucose, 5 L-alanine, 2 L-leucine. The solution was continuously gassed with 5% C02-95% 02. To measure fluid transport, 10 mM creatinine was added to both the perfusate and the bath solution ( 13). In this experiment, tubules were perfused at slow flow rates ( 1-2 nl/mm per min). The creatinine concentrations in the perfusate, bath, and the collected fluid were measured by using a continuous-flow ultramicrocolorimeter (Otsuka Electronics, Osaka) (29) . The rate of fluid absorption was calculated as Jv = (XL/XO -1 )VL/L, where XL is the concentration ofcreatinine in the collected fluid, X0 is the concentration ofcreatinine in the perfusate, VL is the rate at which fluid is collected at the end ofthe tubule, and L is the tubule length.
Net chloride transport study using isolated tubule perfusion. The effects of AVP and ANP on the net chloride absorption and potential 350 H. Nonoguchi, K. Tomita, and F. Marumo difference (PD) in IMAL and sMAL were studied by using the same isolated tubule perfusion as in the fluid transport study. Tubules were perfused at relatively fast flow rates (5-15 nl/mm per min).
At first, the change of J0 with time was examined in both 1MAL
and sMAL. Then, the effect ofAVP on Ja was examined both in 1MAL
and in sMAL. Tubules were perfused and bathed in the same solution at 370C. Usually -45-90 min for IMAL and 20-60 min for sMAL were allowed for equilibration, in that the decrease of Ja with time was larger in sMAL than in 1MAL. After two to five collections, 10-10 M AVP was added only to the bath. Two to five experimental collections were made after 15-20 min. Next, the effect ofANP on Ja was studied in the absence of AVP. After control collections, 10-8 M ANP was added only to the bath. Finally, the effect ofANP was examined in the presence ofAVP. For sMAL, 10-10 M AVP was added to the bath from the beginning. After control collections, 10-8 M ANP or vehicle was added to the bath. Experimental collections were started after 15 min. Chloride concentrations in the perfusate, bath, and the collected fluid were measured using a free-flow ultramicrocolorimeter (Otsuka Electronics) (30) Effect ofA VP on Jci and PD in iMAL and sMAL (Table I) . Jc0 decreased with time in both 1MAL and sMAL (series 1 of Table I, 4-5°5 0 Figure 4 . Na-K-ATPase activity in 1MAL and sMAL. Na-K-ATPase activity was determined as described previously (26) . Fig. 10 ) and PD by 11% (3.6±0.5, 3.2±0.5, and 3.4±0.7 mV, respectively, before, during, and after ANP, n = 10, P < 0.05; series 7 of Table II) . 1010 M ANP also inhibited AVP-stimulated Ja in 1MAL by 26% (70.3±11.4, 51.7±13.6, and 59.0±16.0 pmol/mm per min, respectively before, during, and after ANP, n = 8, P < 0.02; middle panel of Fig. 10 ) and PD by 14% (3.7±1.3, 3.2±1.1, and 3.4±1.1 mV, respectively, before, during, and after ANP, n = 8, P < 0.02; series 8 of Table II ). Finally, i0-' to 1i0-M cGMP significantly inhibited AVP-stimulated Ja (142.5±17.3, 85.6± 12.6, and 105.6±9.5 pmol/mm per min, respectively, before, during, and after ANP, n = 6, P < 0.0 1; right panel ofFig. 10) and PD (3.7±0.3, 3.3±0.3, and 3.3±0.3 mV, before, during, and after ANP, respectively, n = 6, P < 0.05; series 9 of Table II) .
Discussion
There has been interest in the past regarding the possibility of internephron heterogeneity (22, 23), i.e., differences between long-and short-looped nephrons. The structural and functional significance of having both long-and short-loop nephrons is still unclear. Bankir and de Rouffignac (23) have pointed out that there is a good correlation between the urineconcentrating ability and the degree of nephron heterogeneity; i.e., the juxtamedullary-to-superficial ratio for glomerular size, proximal tubule length, and single-nephron glomerular filtration rate is high in desert rodents. Concerning the heterogeneity of MAL, there have been no previous reports on functional differences between 1MAL and sMAL. In fact, rarely have the two been distinguished (27) , partially because of the technical difficulty in discriminating between them. Knepper (27) Effects showed that there was no difference in urea permeability between IMAL and sMAL.
In the present study, we have observed functional differences between IMAL and sMAL for the first time. Our results, showing differences in Na-K-ATPase activities; AVP-, glucagon-, and calcitonin-stimulated cAMP production; ANP-stimulated cGMP production; and AVP-stimulated electrogenic J0 in the two segments, raise the possibility that other functional differences may exist between the two. These findings may help to explain some apparent discrepancies in the literature. For example, although AVP stimulates adenylate cyclase in rat MAL ( 17), no effect of AVP was seen on NaCl transport in isolated perfused rat MAL ( 18) . The negative result may have been obtained because predominantly sMAL were dissected. Good though AVP stimulates adenylate cyclase in MAL from rodents, no effect was seen on MAL from human kidneys (32) . inhibits AVP-stimulated but not unstimulated electrogenic Ja only in 1MAL. Because AVP did not stimulate Ja in sMAL, we may have failed to see any effect of ANP on Ja in sMAL. The effect of ANP on bicarbonate transport must be studied also in 1MAL and sMAL, in that AVP is known to inhibit bicarbonate absorption in MAL (3 1). Based on previous studies, the chief sites of ANP action were thought to be in glomeruli, IMCD, and CCD (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) 24) . Although ANP inhibits Na and fluid reabsorption in IMCD and CCD, which can contribute substantially to the natriuresis and diuresis of ANP, the results of micropuncture studies (7, 14, 33) (6, 12, (34) (35) (36) . Our present data completely agree with these data. However, a direct effect ofANP on the Na channel in IMCD has been also reported (9) . The effect ofANP in this segment is thought to be mediated by cGMP, because cGMP mimicked the effect of ANP. Urinary cGMP is thought to be a biological marker of the renal activity of ANP (37) . ANP increased cGMP accumulation in both 1MAL and sMAL in the presence of phosphodiesterase inhibitor, IBMX. Terada et al. (38) reported the presence of guanylate-cyclase-coupled ANP receptors in MAL. However, the effect of ANP on cGMP accumulation in both 1MAL and sMAL was undetectable without IBMX. More studies may be required to show clearly that cGMP is a second messenger of ANP in MAL. The second messenger of AVP for stimulating chloride absorption is cAMP. The interaction ofthe cAMP and cGMP systems in MAL is not known. In human fibroblasts, ANP reduces cAMP content by activating cAMP phosphodiesterase (39) , but this mechanism seems to be specific to fibroblasts. Stimulation of protein kinase C by endothelin is known to decrease AVP-stimulated cAMP synthesis in collecting ducts (40) . However, ANP did not decrease AVP-stimulated cAMP synthesis in MAL (24) . So, the mechanism ofthe inhibition of AVP action by ANP in MAL is still unknown. NaCl absorption in MAL is very high, whereas water permeability is I AVP IO -'OM I P<0.01 Abbreviations are as in Table I , except for the following: C, control period (AVP only); E, experimental period (AVP + ANP or cGMP); R, recovery period (AVP only).
* P < 0.05; * P < 0.02; § P < 0.01 (the value of the experimental period was compared with the mean value of the control and recovery periods).
quite low. Electrogenic Cl-reabsorption depends on at least four membrane transport pathways (20, 21) : an apical Na+-K+-2CI-cotransporter, an apical K+ channel, a basolateral Cl-channel, and Na-K-ATPase in the basolateral membrane. We have not studied the mechanism of this action. In theory, ANP could decrease electrogenic Cl -transport through effects on any of these pathways. Recently, an inhibitory effect of ANP on Na-K-ATPase activity in MAL has been reported (41 ) . This could be one of the mechanisms of ANP action in 1MAL. Measurements of intracellular electrical potential and ion activities will be required to resolve this issue. It has been recently reported that the ANP-receptor/guanylate cyclase gene is a member of a family of membrane-bound guanylate cyclases whose extracellular domains function as peptide receptors (42) . It is possible that a member of this family besides the ANP receptors is present in 1MAL and may mediate inhibition ofNaCl transport. Two possible physiological agonists for this receptor are brain natriuretic peptide (43) and urodilatin (44) . It will be important to test whether these agents cause a greater increase in cGMP production and a greater inhibition of NaCl transport in this segment.
In summary, we showed that 1MAL is functionally different from sMAL and that ANP inhibits AVP-stimulated Ja in 1MAL. NaCl reabsorption in this segment is the largest among distal nephron segments and is the source of the electrochemical potential energy that drives the countercurrent multiplication system. We propose that this effect may account for a significant part of ANP-induced natnuresis in vivo. Our data also support the importance of long-loop nephrons for urine concentration.
